A detailed history of Lpf Advisors LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Lpf Advisors LLC holds 4,196 shares of MRNA stock, worth $217,394. This represents 0.24% of its overall portfolio holdings.

Number of Shares
4,196
Previous 3,883 8.06%
Holding current value
$217,394
Previous $461 Million 39.19%
% of portfolio
0.24%
Previous 0.43%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

BUY
$63.64 - $125.14 $19,919 - $39,168
313 Added 8.06%
4,196 $280 Million
Q2 2024

Jul 12, 2024

BUY
$101.21 - $166.61 $392,998 - $646,946
3,883 New
3,883 $461 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $20.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Lpf Advisors LLC Portfolio

Follow Lpf Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpf Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpf Advisors LLC with notifications on news.